| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c19aaa6b5ffdbeb95eaafc820ff0cb86 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4808
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2027
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2031
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2009
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-402
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2018
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2013
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4015
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6876 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-402
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 |
| filingDate |
2009-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f94d606d13750eb6c9f443a806e4bc34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_462b8d4747a91372d8311002195db58c |
| publicationDate |
2010-09-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
MA-31664-B1 |
| titleOfInvention |
ORAL CONTROLLED RELEASE FORMULATIONS OF ION CHANNEL MODULATION COMPOUNDS AND ASSOCIATED METHODS FOR PREVENTING ARYTHMIA |
| abstract |
The invention relates to methods for the treatment and prevention of rheumatism and other diseases or disorders using Ion Channel Modulation Compounds, including Vernakalant Hydrochloride. THIS INVENTION FURTHER PROVIDES CONTROLLED RELEASE FORMULATIONS AND ORAL VERNAKALANT HYDROCHLORIDE ASSAYS, WHICH ARE EFFECTIVE IN PREVENTING ARYTHMIA. CERTAIN METHODS AND FORMULATIONS OF THIS INVENTION ARE SUITABLE FOR THE TREATMENT AND PREVENTION OF ARRHYTHMIA AND OTHER DISEASES OR DISORDERS IN SUBJECTS IDENTIFIED AS MEDICAMENTOUS METABOLISM MODIFIED BY THE POLYMORPHISM OF THE GENE ENCODING CYTOCHROME P450 2D6. |
| priorityDate |
2007-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |